Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.
Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...
Yours UK on MSN
What happens when you stop weight loss injections: How the Fast 800 supports long-term success
“This muscle loss can be offset by doing resistance training and eating plenty of protein ,” Dr Mosley says. The Fast 800 now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback